Bipolar surprise: mood disorder endures antidepressant setback.Contrary to the expectations of many mental-health clinicians, a large-scale study finds that severe depression in patients with bipolar disorder bipolar disorder, formerly manic-depressive disorder or manic-depression, severe mental disorder involving manic episodes that are usually accompanied by episodes of depression. responds no better to a combination of antidepressant antidepressant, any of a wide range of drugs used to treat psychic depression. They are given to elevate mood, counter suicidal thoughts, and increase the effectiveness of psychotherapy. medications and mood-stabilizing drugs than it does to mood stabilizers alone. In another challenge to clinical lore, the federally funded investigation indicates that antidepressant use doesn't hasten the emergence of manic symptoms, such as grandiose thinking and euphoric feelings, in patients with bipolar disorder. Mild-to-severe versions of bipolar disorder afflict af·flict tr.v. af·flict·ed, af·flict·ing, af·flicts To inflict grievous physical or mental suffering on. [Middle English afflighten, from afflight, nearly 4 percent of adults at some time in their lives. The illness features swings between periods of depression and mania. Treatment typically includes mood stabilizers such as lithium or other mania-reducing drugs. Clinicians often treat bipolar depression with antidepressants Antidepressants Medications prescribed to relieve major depression. Classes of antidepressants include selective serotonin reuptake inhibitors (fluoxetine/Prozac, sertraline/Zoloft), tricyclics (amitriptyline/ Elavil), MAOIs (phenelzine/Nardil), and heterocyclics as well, although they have worried that these substances may chemically jolt patients from depression into mania. Antidepressants are safe to use with mood stabilizers but ease bipolar depression no better than placebo pills do, report psychiatrist Gary S. Sachs of Massachusetts General Hospital Massachusetts General Hospital Health care The major teaching hospital for Harvard Medical School, widely regarded as one of the best health care centers in the world in Boston and his colleagues. Their investigation, the largest ever of bipolar disorder, appears online and in the April 26 New England Journal of Medicine The New England Journal of Medicine (New Engl J Med or NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It is one of the most popular and widely-read peer-reviewed general medical journals in the world. . The researchers studied 366 volunteers diagnosed with bipolar disorder at any of 22 psychiatric centers in the united States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Participants included individuals with severe and moderate forms of mania. Many had also experienced other mental ailments, such as anxiety disorders Anxiety disorders A group of distinct psychiatric disorders characterized by marked emotional distress and social impairment, including generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, and posttraumatic stress disorder. , substance abuse, and psychosis. At the start of the study, the volunteers exhibited only symptoms of depression. Physicians first made sure that each patient was taking an appropriate dose of a mood-stabilizing drug. Volunteers then randomly received one of two antidepressants--bupropion (Wellbutrin) or paroxetine paroxetine /par·ox·e·tine/ (pah-rok´se-ten) a selective serotonin uptake inhibitor used as the hydrochloride salt to treat depression and obsessive-compulsive, panic, and social anxiety disorders. (Paxil)--or a placebo. Most participants also received psychotherapy. After at most 26 weeks of treatment, 42 of 179 patients receiving antidepressants had shown good emotional health for at least 8 consecutive weeks. Comparable emotional stability characterized 51 of 187 patients receiving placebos. Those response rates weren't significantly different, the researchers calculate. Only about 10 percent of volunteers taking either antidepressants or placebos shifted quickly from depression into mania. The results held true whether or not patients attended psychotherapy sessions. In contrast, research reviews published in 2004 and 2006 reported that antidepressants boost the success of mood stabilizers for bipolar depression. However, the patients whose data were analyzed in those reviews had no psychiatric conditions other than bipolar disorder, often didn't receive psychotherapy, and were tracked for 3 months at most. "It turns out that antidepressants don't help [patients with bipolar disorder] if they're already taking a mood stabilizer," says psychiatrist Thomas R. Insel, director of the National Institute of Mental Health The National Institute of Mental Health (NIMH) is part of the federal government of the United States and the largest research organization in the world specializing in mental illness. in Bethesda, Md. Disappointingly, bipolar disorder often resists treatment with any available drug, he adds. Clinicians must adjust treatment to an individual's symptoms, comments psychiatrist Robert H. Belmaker of Ben Gurion University of the Negev in Beersheba, Israel, in an editorial published with the new report. For example, Belmaker prescribes only antidepressants to patients with severe depression that alternates with mild mania and gives mood stabilizers to most other bipolar patients. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion